These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14638514)

  • 1. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Capilla J; Serena C; Pastor FJ; Ortoneda M; Guarro J
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3976-8. PubMed ID: 14638514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.
    Capilla J; Guarro J
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4009-11. PubMed ID: 15388467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J
    Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental murine scedosporiosis: histopathology and azole treatment.
    Rodríguez MM; Pastor FJ; Salas V; Calvo E; Mayayo E; Guarro J
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3980-4. PubMed ID: 20547805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
    Ergin C; Kutlu M; Arıkan Akdağlı S; Sarıbaş Z; Aydeniz Ozansoy F; Sarı I; Dursunoğlu N
    Mikrobiyol Bul; 2013 Apr; 47(2):351-5. PubMed ID: 23621736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: report of a case and review of the Brazilian reports on scedosporiosis.
    Oliveira Fde M; Unis G; Hochhegger B; Severo LC
    Rev Inst Med Trop Sao Paulo; 2013; 55(2):121-3. PubMed ID: 23563766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
    Warn PA; Sharp A; Mosquera J; Spickermann J; Schmitt-Hoffmann A; Heep M; Denning DW
    J Antimicrob Chemother; 2006 Dec; 58(6):1198-207. PubMed ID: 17071636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy in treatment of murine infection by Fusarium solani.
    Ruíz-Cendoya M; Mariné M; Guarro J
    J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the mouse model for studying the efficacy of voriconazole.
    Graybill JR; Najvar LK; Gonzalez GM; Hernandez S; Bocanegra R
    J Antimicrob Chemother; 2003 Jun; 51(6):1373-6. PubMed ID: 12746374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
    Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
    J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Ruíz-Cendoya M; Pastor J; Guarro J
    Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of voriconazole in the treatment of emerging mycoses].
    Pastor FJ; Guarro J
    Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.
    Vincent AL; Cabrero JE; Greene JN; Sandin RL
    Cancer Control; 2003; 10(5):414-9. PubMed ID: 14581897
    [No Abstract]   [Full Text] [Related]  

  • 17. Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
    Benamu E; Yu AT; Xie L; Fernandez-Pol S; Liu AY; Ho DY
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29111602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
    Fernández-Silva F; Capilla J; Mayayo E; Guarro J
    Mycoses; 2014 Feb; 57(2):121-4. PubMed ID: 23879298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
    Lackner M; Fernández-Silva F; Guarro J; Lass-Flörl C
    J Antimicrob Chemother; 2014 Nov; 69(11):3027-32. PubMed ID: 24986494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatives to amphotericin B for Candida rugosa infection.
    Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
    J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.